Viking Therapeutics, Inc. (VKTX) Stock Slides as Market Rises: Facts to Know Before You Trade

Company Performance - Viking Therapeutics, Inc. closed at $23.91, reflecting a -0.99% change from the previous session, underperforming the S&P 500's daily gain of 0.38% [1] - The company's shares have decreased by 6.03% over the past month, compared to the Medical sector's loss of 3.56% and the S&P 500's loss of 5.59% [1] Earnings Forecast - The upcoming earnings disclosure is anticipated to show an EPS of -$ 0.34, indicating a 30.77% decline from the same quarter last year [2] Analyst Estimates - Recent adjustments to analyst estimates for Viking Therapeutics are crucial as they reflect changing business trends, with positive revisions indicating analyst optimism about the company's profitability [3] - The Zacks Rank system, which incorporates these estimate changes, suggests that estimate revisions correlate with near-term share price momentum [4] Zacks Rank - Viking Therapeutics currently holds a Zacks Rank of 3 (Hold), with no changes in the Zacks Consensus EPS estimate over the past month [5] - The Zacks Rank system has shown that 1 ranked stocks have yielded an average annual return of +25% since 1988 [5] Industry Overview - The Medical - Biomedical and Genetics industry, which includes Viking Therapeutics, has a Zacks Industry Rank of 66, placing it in the top 27% of over 250 industries [6] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [6]